The health risk associated with tobacco use in people with severe mental illness is much higher than the general population. Among them, patients with schizophrenia are the population with perhaps the highest risk for nicotine addition. Current conceptualizations of the possible etiologies of the severe schizophrenia-smoking comorbidity include self-medication for neurocognition deficits, overcoming antipsychotic medication side effects, and shared nicotinic molecular pathways. However, the underlying brain circuitry for the comorbidity is unknown. Identifying brain comorbidity circuitry is critical for developing valid biomarkers for clinical therapeutic development, individualizing treatment selection and outcome prediction. Recent data suggest that the cingulate-ventral striatum circuit appears to be one of the key pathways associated with nicotine addiction. These same areas are also among the regions most commonly implicated in schizophrenia, and additional preliminary studies suggest that the same circuit is impaired in schizophrenia. Therefore, we hypothesize that abnormal cingulate-ventral striatum circuit is a key path for schizophrenia/nicotine addiction comorbidity. We propose to test the hypotheses that the cingulate-ventral striatum circuit is abnormal in nicotine addiction and in schizophrenia, and that schizophrenia pathology disrupts this circuit and predisposes patients to more severe nicotine addiction, leading to the severe nicotine addiction/schizophrenia comorbidity. We will also examine the clinical validities of the circuit in prediction of long-term smoking behavioral change, in genetics, and in its relationships to putative addiction mechanisms. Identifying the key brain circuits associated with smoking in this high risk population will provide concrete biomarkers for new therapeutic development, and ultimately reducing the smoking related health burden in schizophrenia patients. In addition, as public health efforts have reduced smoking, those who still smoke in the population may be more dependent and more treatment-resistant. An effort targeting the population most addicted to smoking may also yield novel perspectives to treat nicotine addiction in the general population.

Public Health Relevance

People with schizophrenia have high rate of smoking, which is often resistant to available treatment. This study aims to identify the brain circuit responsible for the smoking comorbidity in these patients, which should lead to better treatment strategy for reducing smoking and smoking related health burden in schizophrenia patients and perhaps also in other treatment-resistant smokers in the general population.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Lin, Yu
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Maryland Baltimore
Schools of Medicine
United States
Zip Code
Du, Xiaoming; Choa, Fow-Sen; Summerfelt, Ann et al. (2015) Neural summation in human motor cortex by subthreshold transcranial magnetic stimulations. Exp Brain Res 233:671-7
Rao, Jagadeesh; Chiappelli, Joshua; Kochunov, Peter et al. (2015) Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls. Neurodegener Dis 15:38-44
Wright, Susan N; Kochunov, Peter; Chiappelli, Joshua et al. (2014) Accelerated white matter aging in schizophrenia: role of white matter blood perfusion. Neurobiol Aging 35:2411-8
Chiappelli, Joshua; Nugent, Katie L; Thangavelu, Kavita et al. (2014) Assessment of trait and state aspects of depression in schizophrenia. Schizophr Bull 40:132-42
Kochunov, Peter; Hong, L Elliot (2014) Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull 40:721-8
Du, Xiaoming; Summerfelt, Ann; Chiappelli, Joshua et al. (2014) Individualized brain inhibition and excitation profile in response to paired-pulse TMS. J Mot Behav 46:39-48
Nugent, Katie L; Million-Mrkva, Amber; Backman, Joshua et al. (2014) Familial aggregation of tobacco use behaviors among Amish men. Nicotine Tob Res 16:923-30
Chiappelli, Joshua; Kochunov, Peter; DeRiso, Katherine et al. (2014) Testing trait depression as a potential clinical domain in schizophrenia. Schizophr Res 159:243-8
Chiappelli, Joshua; Pocivavsek, Ana; Nugent, Katie L et al. (2014) Stress-induced increase in kynurenic acid as a potential biomarker for patients with schizophrenia and distress intolerance. JAMA Psychiatry 71:761-8
Kochunov, Peter; Chiappelli, Joshua; Wright, Susan N et al. (2014) Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia. Psychiatry Res 223:148-56

Showing the most recent 10 out of 24 publications